These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 24458369)
1. Laboratory policies on reporting secondary findings in clinical whole exome sequencing: initial uptake of the ACMG's recommendations. Hufnagel SB; Antommaria AH Am J Med Genet A; 2014 May; 164A(5):1328-31. PubMed ID: 24458369 [No Abstract] [Full Text] [Related]
2. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories. Ackerman SL; Koenig BA AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714 [TBL] [Abstract][Full Text] [Related]
3. Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling. Smith LA; Douglas J; Braxton AA; Kramer K J Genet Couns; 2015 Aug; 24(4):654-62. PubMed ID: 25403901 [TBL] [Abstract][Full Text] [Related]
4. Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs). Ploug T; Holm S PLoS One; 2017; 12(7):e0179935. PubMed ID: 28671958 [TBL] [Abstract][Full Text] [Related]
5. Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing. Shahmirzadi L; Chao EC; Palmaer E; Parra MC; Tang S; Gonzalez KD Genet Med; 2014 May; 16(5):395-9. PubMed ID: 24113345 [TBL] [Abstract][Full Text] [Related]
6. Who's on first in exome and whole genome sequencing? Is it the patient or the incidental findings? Rosenblatt DS Mol Genet Metab; 2013; 110(1-2):1-2. PubMed ID: 23809103 [No Abstract] [Full Text] [Related]
7. Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease. Hegde M; Santani A; Mao R; Ferreira-Gonzalez A; Weck KE; Voelkerding KV Arch Pathol Lab Med; 2017 Jun; 141(6):798-805. PubMed ID: 28362156 [TBL] [Abstract][Full Text] [Related]
8. Management of Incidental Findings in Clinical Genomic Sequencing. Krier JB; Green RC Curr Protoc Hum Genet; 2015 Oct; 87():9.23.1-9.23.16. PubMed ID: 26439717 [TBL] [Abstract][Full Text] [Related]
9. Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing. Allyse M; Michie M Trends Biotechnol; 2013 Aug; 31(8):439-41. PubMed ID: 23664778 [No Abstract] [Full Text] [Related]
10. Research participants in NGS studies want to know about incidental findings. Jelsig AM; Qvist N; Brusgaard K; Ousager LB Eur J Hum Genet; 2015 Oct; 23(10):1423-6. PubMed ID: 25604854 [TBL] [Abstract][Full Text] [Related]
11. On the justifiability of ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. May T J Law Med Ethics; 2015; 43(1):134-42. PubMed ID: 25846044 [TBL] [Abstract][Full Text] [Related]
12. Clinical exome performance for reporting secondary genetic findings. Park JY; Clark P; Londin E; Sponziello M; Kricka LJ; Fortina P Clin Chem; 2015 Jan; 61(1):213-20. PubMed ID: 25414276 [TBL] [Abstract][Full Text] [Related]
13. Revealing the results of whole-genome sequencing and whole-exome sequencing in research and clinical investigations: some ethical issues. Hallowell N; Hall A; Alberg C; Zimmern R J Med Ethics; 2015 Apr; 41(4):317-21. PubMed ID: 25038088 [TBL] [Abstract][Full Text] [Related]
14. Predictive genetic testing for adult-onset disorders in minors: a critical analysis of the arguments for and against the 2013 ACMG guidelines. Anderson JA; Hayeems RZ; Shuman C; Szego MJ; Monfared N; Bowdin S; Zlotnik Shaul R; Meyn MS Clin Genet; 2015 Apr; 87(4):301-10. PubMed ID: 25046648 [TBL] [Abstract][Full Text] [Related]
15. Genetics professionals' perspectives on reporting incidental findings from clinical genome-wide sequencing. Lohn Z; Adam S; Birch P; Townsend A; Friedman J Am J Med Genet A; 2013 Mar; 161A(3):542-9. PubMed ID: 23401068 [TBL] [Abstract][Full Text] [Related]
16. Choices of incidental findings of individuals undergoing genome wide sequencing, a single center's experience. Bishop CL; Strong KA; Dimmock DP Clin Genet; 2017 Jan; 91(1):137-140. PubMed ID: 27392285 [TBL] [Abstract][Full Text] [Related]
17. Reporting incidental findings in genomic scale clinical sequencing--a clinical laboratory perspective: a report of the Association for Molecular Pathology. Hegde M; Bale S; Bayrak-Toydemir P; Gibson J; Jeng LJ; Joseph L; Laser J; Lubin IM; Miller CE; Ross LF; Rothberg PG; Tanner AK; Vitazka P; Mao R J Mol Diagn; 2015 Mar; 17(2):107-17. PubMed ID: 25684271 [TBL] [Abstract][Full Text] [Related]
18. How do consent forms for diagnostic high-throughput sequencing address unsolicited and secondary findings? A content analysis. Vears DF; Niemiec E; Howard HC; Borry P Clin Genet; 2018 Oct; 94(3-4):321-329. PubMed ID: 29888485 [TBL] [Abstract][Full Text] [Related]
20. Patients' Choices for Return of Exome Sequencing Results to Relatives in the Event of Their Death. Amendola LM; Horike-Pyne M; Trinidad SB; Fullerton SM; Evans BJ; Burke W; Jarvik GP J Law Med Ethics; 2015; 43(3):476-85. PubMed ID: 26479557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]